TW200918098A - Modified growth hormone polypeptides - Google Patents

Modified growth hormone polypeptides Download PDF

Info

Publication number
TW200918098A
TW200918098A TW097131758A TW97131758A TW200918098A TW 200918098 A TW200918098 A TW 200918098A TW 097131758 A TW097131758 A TW 097131758A TW 97131758 A TW97131758 A TW 97131758A TW 200918098 A TW200918098 A TW 200918098A
Authority
TW
Taiwan
Prior art keywords
leu
ser
seq
nucleic acid
acid sequence
Prior art date
Application number
TW097131758A
Other languages
English (en)
Chinese (zh)
Inventor
Richard Ross
Jon Sayers
Peter Artymiuk
Original Assignee
Asterion Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asterion Ltd filed Critical Asterion Ltd
Publication of TW200918098A publication Critical patent/TW200918098A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
TW097131758A 2007-10-10 2008-08-20 Modified growth hormone polypeptides TW200918098A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97901007P 2007-10-10 2007-10-10
GBGB0719818.7A GB0719818D0 (en) 2007-10-11 2007-10-11 Growth hormone fusion polypeptides

Publications (1)

Publication Number Publication Date
TW200918098A true TW200918098A (en) 2009-05-01

Family

ID=38787949

Family Applications (1)

Application Number Title Priority Date Filing Date
TW097131758A TW200918098A (en) 2007-10-10 2008-08-20 Modified growth hormone polypeptides

Country Status (17)

Country Link
US (2) US8273552B2 (cg-RX-API-DMAC7.html)
EP (2) EP2886553A1 (cg-RX-API-DMAC7.html)
JP (1) JP5697983B2 (cg-RX-API-DMAC7.html)
KR (1) KR20100067686A (cg-RX-API-DMAC7.html)
CN (1) CN101932600B (cg-RX-API-DMAC7.html)
AR (1) AR068038A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008309386A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0818639A2 (cg-RX-API-DMAC7.html)
CA (1) CA2701369A1 (cg-RX-API-DMAC7.html)
DK (1) DK2209798T3 (cg-RX-API-DMAC7.html)
ES (1) ES2532600T3 (cg-RX-API-DMAC7.html)
GB (1) GB0719818D0 (cg-RX-API-DMAC7.html)
IL (1) IL203073A0 (cg-RX-API-DMAC7.html)
MX (1) MX2010003892A (cg-RX-API-DMAC7.html)
RU (1) RU2471808C2 (cg-RX-API-DMAC7.html)
TW (1) TW200918098A (cg-RX-API-DMAC7.html)
WO (1) WO2009047474A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606946D0 (en) * 2006-04-06 2006-05-17 Asterion Ltd Polypeptide antagonist
GB201104285D0 (en) 2011-03-15 2011-04-27 Asterion Ltd Modified receptor fusion proteins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH20A (fr) * 1888-12-05 Joseph Magnat Une pompe à bière automatique fonctionnant par la pression de l'eau
ATE455171T1 (de) * 1995-09-21 2010-01-15 Genentech Inc Varianten des menschlichen wachstumshormons
GB0018891D0 (en) * 2000-08-01 2000-09-20 Novartis Ag Organic compounds
CA2447632C (en) * 2000-06-16 2011-08-02 Asterion Limited Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor
ATE509097T1 (de) 2001-11-21 2011-05-15 Us Health Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna
GB2384001B (en) * 2001-12-14 2004-02-04 Asterion Ltd Chimeric growth hormone-growth hormone receptor proteins
WO2004090135A2 (en) 2003-04-09 2004-10-21 Asterion Limited Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol
MX2007001180A (es) * 2004-07-26 2007-04-13 Asterion Ltd Enlazantes.
GB0717985D0 (en) 2007-07-20 2007-10-24 Asterion Ltd Growth hormone fusion proteins
EP2288386A1 (en) * 2008-02-19 2011-03-02 Asterion Limited Modified linkers

Also Published As

Publication number Publication date
CN101932600A (zh) 2010-12-29
CN101932600B (zh) 2014-05-28
BRPI0818639A2 (pt) 2015-04-07
AR068038A1 (es) 2009-10-28
EP2209798A2 (en) 2010-07-28
WO2009047474A2 (en) 2009-04-16
CA2701369A1 (en) 2009-04-16
US20100197589A1 (en) 2010-08-05
US8273552B2 (en) 2012-09-25
JP5697983B2 (ja) 2015-04-08
IL203073A0 (en) 2010-11-30
WO2009047474A3 (en) 2010-09-02
GB0719818D0 (en) 2007-11-21
JP2011507487A (ja) 2011-03-10
ES2532600T3 (es) 2015-03-30
MX2010003892A (es) 2010-05-17
DK2209798T3 (en) 2015-03-23
KR20100067686A (ko) 2010-06-21
US20120322735A1 (en) 2012-12-20
EP2209798B1 (en) 2014-12-31
EP2886553A1 (en) 2015-06-24
AU2008309386A1 (en) 2009-04-16
RU2471808C2 (ru) 2013-01-10
RU2010103159A (ru) 2011-11-20

Similar Documents

Publication Publication Date Title
CN102171343B (zh) Fgfr细胞外结构域酸性区突变蛋白
US8680050B2 (en) Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
US6936439B2 (en) OB fusion protein compositions and methods
JP2024010090A (ja) リラキシン融合ポリペプチドおよびその使用
US20110077199A1 (en) Growth hormone polypeptides and methods of making and using same
CN101679504B (zh) 生长激素融合蛋白
TW202225183A (zh) Gdf15融合蛋白及其用途
CA2275183A1 (en) Ob fusion protein compositions and methods
ES2378424T3 (es) Proteína de fusión de la hormona del crecimiento
CN101268099A (zh) 用于治疗性干预的y4选择性受体激动剂
US20180161443A1 (en) Growth hormone polypeptides and methods of making and using same
CN110678550A (zh) 长效肾上腺髓质素衍生物
WO1998002453A2 (en) Peptidic ligands having a higher selectivity for the vip1 receptor than for the vip2 receptor
DK2209798T3 (en) modified væksthormonpolypeptider
CA3190959A1 (en) Exendin-4 peptide analogues
AU2004202448A1 (en) OB Fusion Protein Compositions and Methods
HK1021388B (en) Ob fusion protein compositions and methods
AU4866700A (en) OB protein compositions and method